Suicidality and Cannabidiol: Opportunities and Challenges

Author(s): Ehsan Moazen-Zadeh, Igor I. Galynker*

Journal Name: Current Neuropharmacology

Volume 19 , Issue 6 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Cannabidiol (CBD) is gaining considerable attention in the research community with promising results in a variety of neuropsychiatric conditions. In particular, there are replicated findings for the therapeutic effects of CBD on psychotic and anxiety symptoms as well as substance use disorders, all of which are highly prevalent in patients who present with suicidality. Meanwhile, there has been a lack of suicide research on cannabidiol. This perspective provides an overview of the available evidence, potential reasons behind the halt in suicide research on cannabidiol, and recommendations for future investigations.

Keywords: Cannabidiol, cannabis, marijuana, suicide, adverse events, psychopharmacology.

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 6
Year: 2021
Page: [733 - 735]
Pages: 3
DOI: 10.2174/1570159X18666201015160417

Article Metrics

PDF: 12